Sidley is representing Eurazeo in its investment in Cranial Technologies. Eurazeo’s investment will support Cranial Technologies’ expansion across the U.S. and other key international markets. Eurazeo is a leading global investment company, with a diversified portfolio of €27 billion in assets under management, including nearly €19.2 billion from third parties, invested in 450 companies. Founded in 1986, Cranial Technologies has provided plagiocephaly treatment to over 300,000 babies in 80 U.S. treatment centers.
The Sidley team was led by corporate partners Chris Rile, Ayo Badejo, and Johnny Skumpija. The team also included corporate associates Nick Behrens, Aideen Brennan, Conner Collins, Connor Grant-Knight, and Melissa Wang; Healthcare partners Meena Datta and Catherine Starks as well as associates Jesse Burbank, Gabriela Illa, Joshua Martin, and Whitney Nebolisa; Food, Drug and Medical Device Compliance and Enforcement partners Deeona Gaskin, Scott Kaplan, and Mauritis Lugard, senior director Alex Smith as well as associates Mia Harris and Josefine Sommer; Global Finance partner Kristen Smith and associate Marc Weinstein; Tax partner Christian Brause and associate Eric Grosshandler; Employee Benefits and Executive Compensation partner Eric Wolf and associate Amanda Casanueva; Technology & IP Transactions partner Lauren Grau and associate Ida Ebeid; Privacy and Cybersecurity counsel Ash Nagdev and associate Mark Prior; Real Estate partner Elizabeth McCloy and associate Joy Kerr; Environmental counsel Maureen Crough and associate Allen Braddock; Global Arbitration, Trade and Advocacy partner James Mendenhall; Labor, Employment and Immigration partner Teresa Reuter as well as associates Martha Clarke and Jason Marsico; and Products Liability partner Elizabeth Curtin.
